Combination of Cytos Biotechnology and Kuros Biosurgery

VISCHER advises Cytos Biotechnology Ltd. (SIX:CYTN) in the proposed combination with Kuros Biosurgery Holding AG. As a result of the combination, the shareholders of Cytos will have ownership in a leading biosciences company in the field of tissue repair and regeneration. Kuros is currently backed by a group of venture investors, including Venture Incubator, LifeCare Partners, LSP (Life Sciences Partners) and Omega Funds. The team at VISCHER is led by Matthias Staehelin with Stefan Grieder, Peter Kühn, Angelo Imperiale, Vincent Reardon (all Corporate) as well as Nadia Tarolli and Isabelle Stebler (both Tax).

Stefan Grieder

Attorney at Law

• Partner

• +41 58 211 39 94
• [email protected]

Peter Kühn

Attorney at Law

• Counsel

• +41 58 211 36 07
• [email protected]

Vincent S. Reardon

Attorney at Law

• Managing Associate

• +41 58 211 32 40
• [email protected]

Matthias Staehelin

Attorney at Law and Civil Law Notary (BS/BL)

• Partner

• +41 58 211 33 53
• [email protected]

Nadia Tarolli Schmidt

Attorney at Law, Swiss Certified Tax Expert

• Partner

• +41 58 211 33 54
• [email protected]